Detalles de la búsqueda
1.
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study.
Br J Haematol;
203(4): 637-650, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37700538
2.
A Screening of Antineoplastic Drugs for Acute Myeloid Leukemia Reveals Contrasting Immunogenic Effects of Etoposide and Fludarabine.
Int J Mol Sci;
21(18)2020 Sep 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32948017
3.
The SOCS3-independent expression of IDO2 supports the homeostatic generation of T regulatory cells by human dendritic cells.
J Immunol;
192(3): 1231-40, 2014 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-24391212
4.
Extracellular ATP exerts opposite effects on activated and regulatory CD4+ T cells via purinergic P2 receptor activation.
J Immunol;
189(3): 1303-10, 2012 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22753942
5.
Ex vivo characterization of acute myeloid leukemia patients undergoing hypomethylating agents and venetoclax regimen reveals a venetoclax-specific effect on non-suppressive regulatory T cells and bona fide PD-1+TIM3+ exhausted CD8+ T cells.
Front Immunol;
15: 1386517, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38812504
6.
An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia.
Blood Adv;
6(1): 87-99, 2022 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34535017
7.
Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T Cells.
Clin Cancer Res;
28(14): 3141-3155, 2022 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35349670
8.
Sunitinib Exerts In Vitro Immunomodulatory Activity on Sarcomas via Dendritic Cells and Synergizes With PD-1 Blockade.
Front Immunol;
12: 577766, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33717062
9.
Long-Term Outcome After Adoptive Immunotherapy With Natural Killer Cells: Alloreactive NK Cell Dose Still Matters.
Front Immunol;
12: 804988, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-35173709
10.
Individual myeloma-specific T-cell clones eliminate tumour cells and correlate with clinical outcomes in patients with multiple myeloma.
Br J Haematol;
148(6): 859-67, 2010 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-20067568
11.
Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
Haematologica;
95(12): 2022-30, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20801903
12.
Flow cytometry T cell profiling in a recent-onset narcoleptic type 1 child: a case report.
Sleep Med;
68: 21-23, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32018187
13.
Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia.
Front Oncol;
9: 1004, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31649875
14.
Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
Stem Cell Res Ther;
9(1): 271, 2018 10 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-30359303
15.
Flow cytometry analysis of T-cell subsets in cerebrospinal fluid of narcolepsy type 1 patients with long-lasting disease.
Sleep Med;
44: 53-60, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29530370
16.
Immunosenescence and Immunotherapy in Elderly Acute Myeloid Leukemia Patients: Time for a Biology-Driven Approach.
Cancers (Basel);
10(7)2018 Jun 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-29932105
17.
The More, The Better: "Do the Right Thing" For Natural Killer Immunotherapy in Acute Myeloid Leukemia.
Front Immunol;
8: 1330, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29097997
18.
ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic Cells.
Front Immunol;
8: 1918, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-29312358
19.
Larger Size of Donor Alloreactive NK Cell Repertoire Correlates with Better Response to NK Cell Immunotherapy in Elderly Acute Myeloid Leukemia Patients.
Clin Cancer Res;
22(8): 1914-21, 2016 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26787753
20.
PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response.
J Immunol Res;
2015: 253191, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25815345